Shelley R. Slade

PARTNER

Direct Line: (202) 537-5903
sslade@vsg-law.com

“One of the most vital qualities for a top whistleblower attorney is the ability to recognize new schemes to defraud our government…”

“I’ve learned during my career that the most vital qualities for a top whistleblower attorney are the insight to recognize the new types of schemes that defraud our nation, the courage to push the government to redress those schemes, the discipline to pay painstaking attention to the nuances of the evidence and the law, and the determination to continue fighting for your clients throughout.   I love what I do because the values of honesty, adherence to duty and compassion for one’s community are paramount to me.”

BACKGROUND

  • Stanford Law, J.D., ’84
  • Partner, Vogel, Slade & Goldstein since 2000
  • Member of the Executive Committees and Boards of Directors of the Taxpayers Against Fraud Education Fund and Taxpayers Against Fraud, 2007-2016
  • Testified as an expert on the False Claims Act before the U.S. Congress, House Committee on the Judiciary, 2008 and 2013
  • Testified as an expert on the False Claims Act before the New York City Council, 2004
  • Testified as an expert on the False Claims Act before the National Association of Attorneys General, 1998
  • Senior Counsel for Health Care for the Civil Division of the U.S. Department of Justice, 1997-1999
  • Trial Attorney, Civil Fraud Section, U.S. Department of Justice, 1990-1997
  • Associate, Arnold & Porter, 1984-1989
  • Princeton University, B.A., magna cum laude, 1980

AWARDS

SPEAKING ENGAGEMENTS

  • 2001-2015: Taxpayers Against Fraud Education Fund’s Annual Conference on the Civil False Claims Act and Qui Tam Enforcement
  • 2014: American Law Institute, False Claims Act Institute
  • 2013: Cornell Law School, False Claims Act Course, Class on First-to-File
  • 2012: Edward Bennett Williams’ Inns of Court
  • 2012: Cornell Law School Class on the False Claims Act, First-to-File Doctrine
  • 2011: Pharmaceutical Regulatory & Compliance Congress
  • 2011: NY Attorney General’s Conference on the New York False Claims Act
  • 2011: ABA Health Care Fraud Institute
  • 2009: ALI-ABA, Live Video Webcast, Federal False Claims Act:  Important Amendments under the Fraud Enforcement & Recovery Act
  • 2008:  The Federalist Society, False Claims Act Amendments Seminar
  • 2005: ABA/CLE White Collar Crime Institute
  • 1999, 2001 & 2004: ABA/NAMFCU Annual Conference on the Civil False Claims Act and Qui Tam Enforcement
  • 2004: Seminar Group Conference on Qui Tam Litigation Under the False Claims Act
  • 2002: Fall Regional Meeting, Virginia Chapter, American Assoc. of HealthCare Administrative Management
  • 2002: ABA/NAMFCU Annual Conference on Health Care Fraud
  • 2001: ABA/HFMA Annual Conference on Medicare Reimbursement & Compliance
  • 2000: Council on Ethical Organizations Conference on Health Care Compliance
  • 1998: D.C. Bar Conference on HHS OIG National Project Guidelines and DOJ False Claims Act Guidance for Civil Health Care Fraud Matters
  • 1998-1999: Various conferences and classes on the False Claims Act sponsored by the Department of Justice to train FBI agents and Department of Justice attorneys

PUBLICATIONS

  • “Off Label Marketing & the False Claims Act,” False Claims Act & Qui Tam Quarterly Review, July 2007
  • “Chilling News: The Department of Justice’s Determination to Unseal all Declined Qui Tams Regardless of Whether Pursued by Relators,” False Claims Act & Qui Tam Quarterly Review, July 2006
  • Westlaw’s False Claims Act treatise, 2004 (Advisory Board member)
  • “Are You of Good Report?,” Healthcare Financial Management, November 2004
  • “Quality-of-Care Issues can Create False Claims Act Exposure,” Healthcare Financial Management, September 2002
  • “False Claims Act May Reach Managed Care Organizations,” Healthcare Financial Management, January 2002
  • “The Government’s New Patient Privacy Rules and Health Care Fraud Compliance and Enforcement,” The Health Lawyer, Vol. 13, No. 4, June 2001
  • “Health-care fraud and the False Claims Act: the Supreme Court Supports a Federal Weapon,” Business Law Today, Vol. 10, No. 1, September/October 2000
  • “Truth and its Consequences: Should You Voluntarily Disclose Overbillings to Law Enforcement,” The Health Lawyer, Vol. 12, No. 5, June 2000
  • “Profiles of Qui Tam Relators: Motives in the Madness,” The Pastin Report on Health Care Compliance, April 2000
  • “False Claims Act Civil Investigative Demands,” The Civil False Claims Act and Qui Tam Enforcement (American Bar Association Center for Continuing Legal Education) (1998)